Cryo Cell International (CCEL) Receivables (2010 - 2026)

Cryo Cell International (CCEL) has reported Receivables for 17 consecutive years, with $7.8 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Receivables rose 0.73% year-over-year to $7.8 million; the TTM figure through May 2026 stood at $7.8 million (up 0.73% YoY), while the FY2025 annual figure was $7.7 million, down 4.74% from the prior year.
• Receivables climbed to $7.8 million in Q2 2026 per CCEL's latest filing, from $7.7 million in the prior quarter.
• Across five years, Receivables topped out at $15.3 million in Q3 2022 and bottomed at $6.7 million in Q4 2022.
• Historically, Receivables has averaged $8.8 million across 5 years, with a median of $7.7 million in 2025.
• Annual changes were most pronounced in 2022 — Receivables soared 165.09% — and 2023, when it plunged 53.65%.
• Cryo Cell International's Receivables stood at $6.7 million in 2022, then climbed by 9.2% to $7.3 million in 2023, then climbed by 11.17% to $8.1 million in 2024, then retreated by 4.74% to $7.7 million in 2025, then increased by 1.31% to $7.8 million in 2026.
• Business Quant data shows CCEL's Receivables at $7.8 million in Q2 2026, $7.7 million in Q1 2026, and $7.7 million in Q4 2025.